Pharma Journalist -

Bristol Myers Squibb announced that it has successfully completed its acquisition of MyoKardia, Inc. in an all cash transaction for approximately $13.1 billion. With the completion of…
Read More...

Exciting Times: 2020 has been an exciting year for gene therapies targeting blood disorders. Despite FDA’s recent rejection of BioMarin’s hemophilia gene therapy program, the…
Read More...

Moderna, Inc. announced a supply agreement with the government of the United Kingdom to supply mRNA-1273, its COVID-19 vaccine candidate, beginning in March 2021 if it is approved for…
Read More...

Assembly Biosciences, Inc. and Door Pharmaceuticals, LLC announced that the companies have signed an exclusive, two-year collaboration and option agreement focused on the development of…
Read More...

Aeterna Zentaris Inc. a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that, through a wholly-owned subsdiary, it…
Read More...

Merck known as MSD outside of the United States and Canada, announced a collaboration with the Bill & Melinda Gates Foundation (the foundation) where the foundation is committing to…
Read More...

Lead Pharma, a clinical stage pharmaceutical company, designing and developing innovative medicines for the treatment of immune mediated diseases and cancer, announced that it has…
Read More...

Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market Amsterdam, 17 November 2020: CPhI & P-MEC China returns as a…
Read More...

Olema Oncology, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women's cancers, announced a clinical…
Read More...

The Phase 3 ENSEMBLE study of the single-dose regimen of JNJ-78436735, the investigational vaccine candidate for the prevention of COVID-19 being developed by the Janssen Pharmaceutical…
Read More...